[{"id":"1b940136-1411-4455-9d96-af20cf1be948","acronym":"","url":"https://clinicaltrials.gov/study/NCT00899080","created_at":"2021-01-18T03:27:19.009Z","updated_at":"2024-07-02T16:37:22.051Z","phase":"","brief_title":"Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide","source_id_and_acronym":"NCT00899080","lead_sponsor":"Eastern Cooperative Oncology Group","biomarkers":" CTSG","pipe":"","alterations":" ","tags":["CTSG"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e lenalidomide • thalidomide"],"overall_status":"Completed","enrollment":" Enrollment 33","initiation":"Initiation: 07/04/2008","start_date":" 07/04/2008","primary_txt":" Primary completion: 08/04/2008","primary_completion_date":" 08/04/2008","study_txt":" Completion: 08/04/2008","study_completion_date":" 08/04/2008","last_update_posted":"2017-05-17"}]